Combipres Eye Drops is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Brimonidine Tartrate 0.2% + Timolol Maleate 0.5% is a medication prescribed for the treatment of open-angle glaucoma and ocular hypertension, which is elevated pressure within the eyes. Open-angle glaucoma is a common eye condition characterized by damage to the optic nerve, often caused by increased fluid buildup in the front part of the eye, leading to increased intraocular pressure.
This medication combines two active ingredients: Brimonidine and Timolol. Brimonidine, a sympathomimetic drug, narrows blood vessels, reducing the flow of aqueous humor in the eye. Timolol, a beta-blocker, reduces the production of aqueous humor by acting on the ciliary body in the eye, consequently lowering intraocular pressure.
The dosage and frequency of Brimonidine Tartrate + Timolol Maleate will be determined by your doctor based on your specific medical condition. Some common side effects of this medication include itching, stinging or burning sensations in the eye, redness, blurred vision, fatigue, drowsiness, headache, and dry mouth. These side effects are usually mild and tend to resolve over time. However, if they persist or worsen, seek medical attention.
It is essential not to discontinue this medication without consulting your doctor. Brimonidine Tartrate + Timolol Maleate should not be used if you have certain medical conditions such as eye infections, allergies, closed-angle glaucoma, thyroid disorders, asthma, chronic obstructive pulmonary disease (COPD), heart, liver, or kidney problems, diabetes, high or low blood pressure, depression, Raynaud's phenomenon (numbness in various parts of the body), or slow heartbeats that lead to fainting.
If you are pregnant, breastfeeding, or taking other prescribed or over-the-counter medications, consult your doctor before using Brimonidine Tartrate + Timolol Maleate. It is not recommended during breastfeeding, as Timolol can pass into breast milk. Always follow your doctor's advice and guidance when using this medication.
Avoid or limit consumption of alcohol while using Combipres Eye Drops.
Combipres Eye Drops is not recommended for use in pregnant women unless considered clearly necessary. Consult your doctor before using Combipres Eye Drops.
Combipres Eye Drops is not recommended for use in breastfeeding mothers since they may pass into the milk. Consult your doctor before using Combipres Eye Drops.
Do not drive or operate machines while using Combipres Eye Drops as it may cause drowsiness, tiredness, or blurred vision. Consult your doctor before using Combipres Eye Drops.
Combipres Eye Drops should be used with caution in patients with kidney problems. Consult your doctor for advice before using Combipres Eye Drops.
Combipres Eye Drops should be used with caution in patients with liver problems. Consult your doctor before using it.
Combipres is a combination of two medicines: Timolol and Brimonidine. Timolol is a beta blocker while Brimonidine is a sympathomimetic. They work by decreasing the production of aqueous humor (fluid in the eye), thereby lowering the increased eye pressure.
This eye drop is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Brimonidine is an alpha 2-adrenoceptor agonist that works to reduce aqueous humor production and increase uveoscleral flow. Timolol is a non-selective beta-adrenergic receptor blocker. It does not have significant intrinsic sympathomimetic activity, direct myocardial depressant activity, or local Anaesth activity. The exact mechanism of the ocular hypotensive effect is unclear, but it is thought to be related to the reduction of aqueous humor formation. beta-blockade also causes a lowering of BP.
The recommended dosage for this eye drop medication is as follows:
This medicine is for external use only. Take it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off extra liquid.
If you are using more than one topical ophthalmic (eye) product, it's important to space the installation of each eye drop at least 5 minutes apart to ensure their effectiveness. Safety and effectiveness in children below the age of 12 years have not been established.
Brimonidine Tartrate: Possibility of an additive or potentiating effect with CNS depressants e.g. alcohol, barbiturates, opiates, sedatives, or anesthetics. Caution when used with ?-blockers (ophthalmic and systemic), antihypertensive, or cardiac glycosides. TCAs can affect the metabolism and uptake of circulating amines.
Timolol: Concomitant admin w/ reserpine may increase hypotension and bradycardia. Additive effects w/ other antihypertensives (e.g. hydralazine, methyldopa). Increased ?-adrenergic blockade (e.g. decreased heart rate) w/ quinidine. Rebound HTN due to abrupt withdrawal of clonidine. The hypotensive effect may be antagonized by NSAIDs (e.g. indomethacin, ibuprofen).
Storage Conditions
Contraindicated in patients with hypersensitivity to any component of this product. Also contraindicated in bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second or third-degree atrioventricular block, overt cardiac failure, and cardiogenic shock.
Patients wearing soft contact lenses should wait for at least 15 min after instilling brimonidine tartrate before inserting soft contact lenses. Renal or hepatic impairment. CV disease. Use with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangitis obliterans. Pregnancy, lactation. Lactation: use caution
Store in a cool & dry place, protected from light. Keep out of reach of children. Do not use more than 4 weeks after opening. It is desirable that the contents should not be used more than four weeks after the first opening of the bottle.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.